NCT00309868View on ClinicalTrials.gov

Study of Nesiritide in Diastolic Heart Failure.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Diastolic Heart Failure
Interventions
DRUG

neseritide

All Listed Sponsors
collaborator

Scios, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00309868 - Study of Nesiritide in Diastolic Heart Failure. | Biotech Hunter | Biotech Hunter